Latest Headlines

  1. LabVantage Solutions Introduces LabVantage CORTEX, Advancing Its LIMS Platform For AI-Driven Laboratory Operations 3/5/2026

    LabVantage Solutions, Inc., a global provider of laboratory informatics solutions and services, today announced the launch of LabVantage CORTEX, a next-generation artificial intelligence (AI), analytics, and automation platform.

  2. Frontage Laboratories Completes Acquisition Of Teddy Lab, Strengthening Global Central Laboratory Capabilities 3/4/2026

    rontage Laboratories, Inc. ("Frontage"), a leading global CRO/CDMO, today announced the completion of the acquisition of Teddy Clinical Research Laboratory (Shanghai), Ltd. ("Teddy Lab"), a leading clinical research laboratory service provider in China.

  3. US BioTek Laboratories Completes Merger With NutriPATH Pathology 3/3/2026

    US BioTek Laboratories, a leading functional laboratory specializing in advanced immunological and integrative diagnostics, today announced the completion of its merger with NutriPATH Pathology, a respected functional pathology laboratory serving integrative and functional medicine practitioners.

  4. Pillar Biosciences Launches oncoReveal® Rapid AML Panel To Support Rapid, Guideline Informed Genomic Insights For Acute Myeloid Leukemia 3/3/2026

    Pillar Biosciences today announced the launch of the oncoReveal® Rapid AML Panel, a focused research-use-only (RUO) DNA next-generation sequencing (NGS) panel designed to help laboratories generate key acute myeloid leukemia (AML) genomic results more efficiently.

  5. PathAI Receives U.S. FDA Breakthrough Device Designation For PathAssist Derm, An AI-Powered Pathology Solution To Transform Dermatopathology Workflow 3/3/2026

    PathAI, Inc., a global leader in artificial intelligence (AI)-powered pathology solutions, today announced that the U.S. Food and Drug Administration (FDA) has granted Breakthrough Device Designation to PathAssist Derm1, designed to analyze digital pathology whole slide images (WSIs) of skin lesions and aid pathologists in their review.

  6. Lucent Diagnostics And Life Line Screening Partner To Bring Advanced Blood-Based Diagnostics To Communities Nationwide 3/2/2026

    Lucent Diagnostics, a brand of Quanterix Corporation today announced a partnership with Life Line Screening (LLS), a national organization focused on identifying asymptomatic risks for chronic conditions in community health settings.

  7. Thermo Fisher Scientific Launches New Color-Based (Chromogenic) Culture Media To Help Detect Candida Infections Faster*, Including Drug-Resistant Candida Auris 3/2/2026

    Thermo Fisher Scientific, the world leader in serving science, today announced the launch of Thermo Scientific Brilliance Candida 2 Agar and Spectra Candida Agar**, new color-based (chromogenic) culture media to help laboratories quickly detect and differentiate clinically important Candida species — including Candida auris, a growing global antimicrobial resistance (AMR) threat1.

  8. Quest Diagnostics Introduces AI Companion To Help Patients Understand And Act On Lab Test Results 3/2/2026

    Quest Diagnostics (NYSE: DGX), a leader in diagnostic information services, today announced Quest AI Companion, a new AI-powered chat feature that helps individuals analyze, understand and act on their Quest laboratory test results with their healthcare provider.

  9. Acupath Laboratories, Inc. Partners With Azer Scientific To Install The First AzerView Digital Pathology Scanner In The United States 2/27/2026

    Three pathology and healthcare technology leaders today announced a partnership that has resulted in the installation of the first LH510 Digital Pathology scanner in the United States, marking a significant milestone in the advancement of digital pathology and diagnostic innovation.

  10. Illumina Whole-Genome Sequencing Technology To Accelerate Rare Disease Testing In Florida 2/27/2026

    Illumina, Inc. (NASDAQ: ILMN) today announced that Illumina Laboratory Services, Illumina's CLIA-certified laboratory, is providing clinical sequencing and interpretation services to the new Diagnostic Lab at Florida Institute for Pediatric Rare Diseases (IPRD) at Florida State University (FSU) College of Medicine, further driving innovation in diagnostics and treatments for rare diseases.